INVESTORS MEDIA CAREERS UNITED STATES Physicians Technology Company ContactAFIB is Personal Clinical Data CLINICAL DATA > CLINICAL STUDIES Clinical Studies 2021 — PRESENT AcQBlate Force Sensing Ablation System US IDE Study for Atrial Fibrillation (AcQForce AF) (N=350). AcQForce AF currently enrolling. NCT04904354 CAUTION: The AcQBlate FORCE Sensing Catheter is an investigational device and is limited by United States law to investigational use. LEARN MORE 2021 — PRESENT AcQBlate Force Sensing Ablation System Study for Atrial Fibrillation (AcQForce AF – EU) (N=350). AcQForce AF-EU currently enrolling. NCT04941391 CAUTION: The AcQBlate FORCE Sensing Catheter is an investigational device and is limited by United States law to investigational use. LEARN MORE 2021 — PRESENT AcQBlate Force Sensing Ablation System used for the treatment of typical atrial flutter in a US Investigational Device Exemption (IDE) study (N=100). AcQForce Flutter currently enrolling. NCT04658940 CAUTION: The AcQBlate FORCE Sensing Catheter is an investigational device and is limited by United States law to investigational use. LEARN MORE 2021 — PRESENT AcQBlate Force Sensing Ablation System used for the treatment of typical atrial flutter in a European and United Kingdom post-market study (N=50). AcQForce Flutter-EU currently enrolling. NCT04657055 CAUTION: The AcQBlate FORCE Sensing Catheter is an investigational device and is limited by United States law to investigational use. LEARN MORE 2019 — PRESENT AcQMap System US Registry – informed therapy in de novo and retreatment AF patients with contact and non-contact technologies (N=500). AcQMap DISCOVER Registry-US currently enrolling. NCT04431544 LEARN MORE 2019 — PRESENT AcQMap System Global Registry – informed therapy in de novo and retreatment AF patients with contact and non-contact technologies (N=500). AcQMap DISCOVER Registry-EU currently enrolling. NCT03893331 LEARN MORE PENDING AcQMap System – US based substrate characterization study (N=100). PLASZMA is not yet enrolling. NCT04512794 2018 AcQMap — informed therapy in retreatment of Persistent AF patients (N = 106) Recover AF enrollment complete. One year results pending 2016 Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER AF) AcQMap — informed therapy in de novo Persistent AF patients (N = 129) UNCOVER AF study complete READ THE PUBLICATION READ THE CLINICAL SUMMARY 2014 Dipole Density Right (and left) Atrial Mapping and Assessment of Therapy in Complex Supraventricular Tachycardia (DDRAMATIC-SVT) AcQMap proof of concept compared to existing technologies in Persistent and Long-Standing Persistent AF patients (N = 85) DDRAMATIC-SVT study complete 2013 Initial experience for safety (N = 12) FIRST IN MAN study complete Copyrights are the property of their respective owners LINKS Product Safety Information Compliance Reimbursement ACUTUS MEDICAL, INC. 2210 Faraday Avenue Suite 100 Carlsbad, CA 92008 Phone: +1-442-232-6080 Fax: +1-442-232-6081 Copyright © 2021 Acutus Medical, Inc.Terms of UsePrivacy Policy